Increased risk of brain metastases among patients with melanoma and PROM2 expression in metastatic lymph nodes

Clin Transl Med. 2020 Dec;10(8):e198. doi: 10.1002/ctm2.198.

Thuy Thi Nguyen^{1

2

3}, Guillaume Gapihan^{1

4}, Pauline Tetu⁵, Frédéric Pamoukdjian^{1

6

7}, Morad El Bouchtaoui¹, Christophe Lebœuf¹, Jean-Paul Feugeas^{8

9}, Justine Paris¹, Barouyr Baroudjian⁵, Julie Delyon^{5

10}, Samia Mourah^{4

10

11}, Céleste Lebbé^{4

5

10}, Anne Janin^{1

4}, Guilhem Bousquet^{1

2

7}, Maxime Battistella^{4

10

12}

¹ INSERM U942, Universités de Paris et Sorbonne Paris Nord, Bobigny, France.
² AP-HP Hôpital Avicenne, Oncologie Médicale, Bobigny, France.
³ Medical Oncology Department A, National Cancer Hospital, Hanoi, Vietnam.
⁴ Hôpital Saint-Louis, Université de Paris, Paris, France.
⁵ Dermatologie, AP-HP Hôpital Saint Louis, Paris, France.
⁶ Médecine Gériatrique, AP-HP Hôpital Avicenne, Bobigny, France.
⁷ Université Sorbonne Paris Nord, Cardiovascular Markers in Stressed Conditions, MASCOT, Bobigny, France.
⁸ INSERM U722, Paris, France.
⁹ Université de Franche-Comté, Besançon, France.
¹⁰ INSERM U976, Paris, France.
¹¹ Solid Tumor Genomic Department, AP-HP, Hôpital Saint Louis, Paris, France.
¹² Laboratoire de Pathologie, AP-HP Hôpital Saint-Louis, Paris, France.

No abstract available

Publication types